Unassociated Document
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): May 27, 2010
 
CHINA MEDICINE CORPORATION
(Exact name of registrant as specified in Charter)
 
Nevada
000-51379
51-0539830
(State of Incorporation)
(Commission File Number)
 (IRS Employer
Identification No.)

2/F, Guangri Tower
No. 9 Siyounan Road 1st Street
Yuexiu District
Guangzhou, China 510600
(Address of registrant’s principal executive office)
 
(8620) 8739-1718 and (8620) 8737-8212
(Registrant’s telephone number, including area code)
 
Check the appropriate box below in the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240. 14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

China Medicine Corporation (the “Company”) held its annual meeting of Stockholders on May 27, 2010 (“Annual Meeting”).  Robert Adler and Yanfang Chen did not stand for reelection as members of the Board of Directors of the Company at the Annual Meeting.

The decision of Mr. Adler and Mr. Chen not to stand for reelection was not the result of any known disagreements between the Company and either Mr. Adler or Mr. Chen on any matter relating to the Company’s operations, policies or practices.

Item 5.07
Submission of Matters to a Vote of Security Holders

Proxies for the Annual Meeting were solicited pursuant to the Company's proxy statement filed on April 19, 2010 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934.

At the Annual Meeting the stockholders elected seven individuals to serve as directors of the Company until the 2011 annual meeting of Stockholders or until their successors have been duly elected and qualified.  The results of the voting were as follows:

 
FOR
WITHHELD
     
Mr. Senshan Yang
31,093,378
64,750
     
Ms. Minhua Liu
31,086,378
71,750
     
Dr. Rachel Gong
31,088,478
69,650
     
Mr. Ryan Shih
31,102,878
55,450
     
Mr. Daniel Shih
31,102,878
55,250
     
Mr. Sean Shao
31,102,878
55,250
     
Mr. Ian Robinson
31,102,878
55,250

There were no abstentions or broker non-votes.
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  CHINA MEDICINE CORPORATION  
       
       
       
 
By:
/s/ Senshan Yang 
  
  Name: 
Senshan Yang 
  
  Title: 
Chief Executive Officer 
  
Date:    June 2, 2010